Publication date: Apr 13, 2019
The myriad of new signals that characterize the complex biology of cancer is compounded by the diversity of the human form.
Characterizing the human ‘phenome’ – the detailed description of the patient and their biological state – is becoming critical for accurate prediction of clinical outcomes of a given therapy and is associated with the development of ‘precision’ or ‘personalized’ cancer medicines.
The implications are important across all of cancer medicine and align with the need for improvements in patient safety, quality of care, clinical outcomes, and patient experience.
- Leading the Charge: How the Personalized Medicine Coalition Promotes Education and Advocacy
- Personalized Healthcare with High Performance Computing in the Cloud
- Automation and artificial intelligence in the clinical laboratory.
- Accelerate DNA Sequencing in Pursuit of Precision Medicine